Image

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

Join our study on Frontotemporal Lobar Degeneration to help advance research.

Recruiting
18 years and older
All
Phase N/A

**Frontotemporal Lobar Degeneration (FTLD)** is a brain disorder affecting behavior, language, and movement. The ALLFTD study examines both sporadic (not family-related) and familial (family-related) types of FTLD. It involves two parts: a "longitudinal arm" with yearly check-ups, and a "biofluid-focused arm" for collecting biological samples.

Participants in the "longitudinal arm" are family members of those with known FTLD genes, or have a family history of FTLD. Sporadic participants should show symptoms without a family history. They may have conditions like Progressive Supranuclear Palsy (PSP) or Behavioral variant Frontotemporal Dementia (bvFTD). The "biofluid-focused arm" includes any FTLD participants, and fewer clinical tests are needed.

  • **Commitment**: Annual visits for comprehensive data collection in the longitudinal arm.
  • **Eligibility**: Family history or specific symptoms are needed for participation.
  • **Exclusions**: Conditions like Alzheimer's, severe alcohol use, or certain brain lesions may disqualify participants.

For more details, visit the study's website: https://www.allftd.org/

Study details
    Frontotemporal Lobar Degeneration (FTLD)
    Progressive Supranuclear Palsy (PSP)
    Corticobasal Degeneration (CBD)
    Behavioral Variant Frontotemporal Dementia (bvFTD)
    Semantic Variant Primary Progressive Aphasia (svPPA)
    Nonfluent Variant Primary Progressive Aphasia (nfvPPA)
    FTD With Amyotrophic Lateral Sclerosis (FTD/ALS)
    Amyotrophic Lateral Sclerosis
    Oligosymptomatic PSP (oPSP)
    C9orf72
    GRN Related Frontotemporal Dementia
    MAPT Gene Mutation
    TBK1 Gene Mutation
    Oligosymptomatic Progressive Supranuclear Palsy

NCT04363684

Mayo Clinic

22 June 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.